JPRN-UMIN000004925已完成未知
The efficacy and safety of direct renin inhibitor aliskiren on the blood glucose control of DPP-IV inhibitor - The efficacy and safety of direct renin inhibitor aliskiren on the blood glucose control of DPP-IV inhibitor
Department of Internal Medicine, School of Medicine, Keio University0 个研究点目标入组 70 人开始时间: 2011年2月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 70years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1. type 1 diabetes mellitus 2. Patients who take both ACE inhibitor and ARB 3. Ptients who have allergy to the study drugs 4. Severe hypertension (180/110 mmHg or higher) 5. Pregnant women, women who want to be pregnant 6. Patients taking cyclosporine 7. Sever liver dysfunction (GOT>80 IU/L, GPT>80 IU/L), renal dysfunction (Cr>1.5(male), 1.4 (female) mg/dl)
研究者
相似试验
已完成
不适用
Therapeutic effects of direct renin inhibitor in end stage kidney disease patients with maintenance hemodialysisHypertension,End stage kidney diseaseJPRN-UMIN000003551Yamamoto general hospital40
招募中
4 期
Therapeutic effects of direct renin inhibitor aliskiren on ambulatory blood pressure profile in essential hypertensivesEssential hypertensionJPRN-UMIN000003936Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine40
已完成
4 期
Therapeutic effects of direct renin inhibitor aliskiren added to AT1 receptor blocker in hypertensive patients with chronic kidney disease.Hypertension Chronic kidney diseaseJPRN-UMIN000002546Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine100
已完成
不适用
A prospective comparison of direct renin inhibitor aliskiren and AT1 receptor blocker in hypertensive patients with chronic kidney disease(CKD).Hypertension Chronic kidney diseaseJPRN-UMIN000008615Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine100
已完成
不适用
The comparative study between direct renin inhibitor and angiotensin II receptor antagonist in hypertensive patients with chronic kidney diseasechronic kidney diseaseJPRN-UMIN000003817Division of Nephrology, Hypertension and Endocrinology, Itabashi Hospital, Nihon University School of Medicine40
